Agenus Inc (AGEN) Stock Price, Quote & News

Latest News on AGEN

Dec 18, 2024, 7:30 AM EST - 4 weeks ago

Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers

Dec 5, 2024, 7:30 AM EST - 6 weeks ago

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs

Nov 27, 2024, 8:15 AM EST - 7 weeks ago

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment

Nov 12, 2024, 10:41 AM EST - 2 months ago

Agenus Inc. (AGEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:00 AM EST - 2 months ago

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

Nov 7, 2024, 10:00 AM EST - 2 months ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

Nov 5, 2024, 7:30 AM EST - 2 months ago

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

Nov 4, 2024, 11:00 AM EST - 2 months ago

November 5 Deadline: Agenus Inc Is Being Sued For Defrauding The Public And Affected Shareholders Are Urged To Contact The Schall Law Firm

Nov 3, 2024, 11:00 AM EST - 2 months ago

The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Agenus Inc.

Nov 2, 2024, 11:00 AM EDT - 2 months ago

Agenus Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 31, 2024, 11:00 AM EDT - 2 months ago

The Schall Law Firm Encourages Investors To Take Part In A Securities Fraud Case Against Agenus Inc.

Oct 31, 2024, 5:45 AM EDT - 2 months ago

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGEN

Oct 30, 2024, 6:54 PM EDT - 2 months ago

Agenus Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 5, 2024 Deadline to file Lead Plaintiff Motion

Oct 30, 2024, 6:30 PM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Oct 28, 2024, 8:43 PM EDT - 2 months ago

Agenus Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 5, 2024 Deadline to file Lead Plaintiff Motion.

Oct 24, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 23, 2024, 12:30 PM EDT - 3 months ago

Agenus Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 5, 2024 to Discuss Your Rights – AGEN

Oct 23, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investors To Join A Securities Fraud Case Against Agenus Inc.

Oct 20, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 18, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

$The Schall Law Firm Encourages Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions$

Oct 17, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions

Oct 16, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 15, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investor Participation In A Case Against Agenus Inc. For Securities Law Violations

Oct 14, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Stockholders Are Urged To Reach Out To The Schall Law Firm

Oct 14, 2024, 10:10 AM EDT - 3 months ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Oct 11, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Encourages Investors To Join A Case Against Agenus Inc. For Securities Law Violations

Oct 10, 2024, 5:45 AM EDT - 3 months ago

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 5, 2024 to Discuss Your Rights - AGEN

Oct 9, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Invites Investor Participation In A Case Against Agenus Inc. For Securities Law Violations

Oct 8, 2024, 1:19 PM EDT - 3 months ago

Agenus Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – AGEN

Oct 8, 2024, 4:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm Urges

Oct 7, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Urges Investor Participation In A Case Against Agenus Inc. For Securities Law Violations

Oct 6, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Impacted Shareholders Are Encouraged To Contact The Schall Law Firm

$The Schall Law Firm Urges Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions$

Oct 5, 2024, 11:00 AM EDT - 3 months ago

The Schall Law Firm Urges Investor Participation In A Case Against Agenus Inc. For Securities Related Infractions

Oct 4, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Encouraged To Help The Schall Law Firm

Oct 2, 2024, 12:55 PM EDT - 3 months ago

Shareholders of Agenus Inc. Should Contact The Gross Law Firm Before November 5, 2024 to Discuss Your Rights – AGEN

Oct 2, 2024, 11:00 AM EDT - 3 months ago

Agenus Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 3 months ago

Market Cap	73.90M
Revenue (ttm)	156.31M
Net Income (ttm)	-245.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-157.23%
Debt to Equity Ratio	-0.05

Volume	377,700
Avg Vol	555,458
Day's Range	N/A - N/A
Shares Out	23.46M
Stochastic %K	70%
Beta	1.27
Analysts	Sell
Price Target	$8.00